Before you trust any doctor I first would look him up to see how much payments he has been taking from Big Pharma for being a thought-leader or for any other things. Big Pharma is marketing about 24 billion dollars to doctors and only 4 billion to us and doctors get well rewarded for writing prescription drugs. Lunch is brought in by Big Pharma reps as well to buy their influence.
https://openpaymentsdata.cms.gov/search
But the AMA was brought up......
AMA plans to eliminate chiropractic[edit]
On November 2, 1963, the AMA Board of Regents created the "Committee on Quackery" with the goals of first containing, and then eliminating chiropractic. H. Doyle Taylor, the Director of the AMA Department of Investigation and Secretary of the Committee on Quackery, outlined the steps needed:[SUP][46][/SUP]
- to ensure that Medicare should not cover chiropractic
- to ensure that the U.S. Office of Education should not recognize or list a chiropractic accrediting agency
- to encourage continued separation of the two national associations
- to encourage state medical societies to take the initiative in their state legislatures in regard to legislation that might affect the practice of chiropractic.
The AMA worked to spread information designed to discredit chiropractic through public media and the scientific literature.[SUP][46][/SUP]
The longstanding feud between chiropractors and medical doctors continued for decades. The AMA labeled chiropractic an "unscientific cult" in 1966,[SUP][7][/SUP] and until 1980 held that it was unethical for medical doctors to associate with "unscientific practitioners".[SUP][47][/SUP] In 1975, an anonymous AMA insider describing himself as a disgruntled AMA staffer and identifying himself as "Sore Throat" released information concerning the Committee on Quackery and its proposed methods to eliminate chiropractic to the press.[SUP][48][/SUP] These papers were the basis of Wilk et al. vs. AMA, the suit brought by Chester Wilk, D.C., of Illinois and five co-plaintiffs against the AMA and several co-defendants. After two trials, on September 25, 1987, Getzendanner issued her opinion that the AMA had violated Section 1, but not 2, of the Sherman Act, and that it had engaged in an unlawful conspiracy in restraint of trade "to contain and eliminate the chiropractic profession." (Wilk v. American Medical Ass'n, 671 F. Supp. 1465, N.D. Ill. 1987).[SUP][8]
source: https://en.wikipedia.org/wiki/History_of_chiropractic
Why would anyone trust the AMA after what happened in 1987 and one chiropractor I know here in Oz, said last year that not much really had changed. He is from the US himself.
Here is list with all the lawsuits that have been settled by Big Pharma so far.
https://en.wikipedia.org/wiki/List_of_largest_pharmaceutical_settlements
[/SUP]
The following is a list of the 20 largest settlements reached between Pundru United States Department of Justice and pharmaceutical companies from 1991 to 2012, ordered by the size of the total settlement. The settlement amount includes both the civil (False Claims Act) settlement and criminal fine. Glaxo's $3 billion settlement included the largest civil, False Claims Act settlement on record,[SUP][1][/SUP] and Pfizer’s $2.3 billion settlement including a record-breaking $1.3 billion criminal fine.[SUP][2][/SUP] Legal claims against the pharmaceutical industry have varied widely over the past two decades, including Medicare and Medicaid fraud, off-labelpromotion, and inadequate manufacturing practices.[SUP][3][/SUP][SUP][4][/SUP] With respect to off-label promotion, specifically, a federal court recognized off-label promotion as a violation of the False Claims Act for the first time in Franklin v. Parke-Davis, leading to a $430 million settlement.[SUP][5][/SUP]
[TABLE="class: wikitable sortable jquery-tablesorter"]
[TR]
[TH="class: headerSort, bgcolor: #F2F2F2, align: center"]Year[/TH]
[TH="class: headerSort, bgcolor: #F2F2F2, align: center"]Company[/TH]
[TH="class: headerSort, bgcolor: #F2F2F2, align: center"]Settlement[/TH]
[TH="class: unsortable, bgcolor: #F2F2F2, align: center"]Violation(s)[/TH]
[TH="class: headerSort, bgcolor: #F2F2F2, align: center"]Product(s)[/TH]
[TH="class: headerSort, bgcolor: #F2F2F2, align: center"]Laws allegedly violated
(if applicable)[/TH]
[/TR]
[TR]
[TD]2012[/TD]
[TD]
GlaxoSmithKline[SUP]
[1][/SUP][/TD]
[TD]$3 billion ($1B criminal, $2B civil)[/TD]
[TD]Criminal: Off-label promotion, failure to disclose safety data.
Civil: paying kickbacks to physicians, making false and misleading
statements concerning the safety of Avandia, reporting false best
prices and underpaying rebates owed under the
Medicaid Drug Rebate Program[/TD]
[TD]
Avandia,
Wellbutrin,
Paxil,
Advair,
Lamictal,
Zofran,
Imitrex,
Lotronex,
Flovent,
Valtrex;[/TD]
[TD]
False Claims Act/
FDCA[/TD]
[/TR]
[TR]
[TD]2009[/TD]
[TD]
Pfizer[SUP]
[2][/SUP][/TD]
[TD]$2.3 billion[/TD]
[TD]Off-label promotion/
kickbacks[/TD]
[TD]
Bextra/
Geodon/
Zyvox/
Lyrica[/TD]
[TD]False Claims Act/FDCA[/TD]
[/TR]
[TR]
[TD]2013[/TD]
[TD]
Johnson & Johnson[SUP]
[6][/SUP][/TD]
[TD]$2.2 billion[/TD]
[TD]Off-label promotion/
kickbacks[/TD]
[TD]
Risperdal/
Invega/
Nesiritide[/TD]
[TD]False Claims Act/FDCA[/TD]
[/TR]
[TR]
[TD]2012[/TD]
[TD]
Abbott Laboratories[SUP]
[7][/SUP][/TD]
[TD]$1.5 billion[/TD]
[TD]Off-label promotion[/TD]
[TD]
Depakote[/TD]
[TD]False Claims Act/FDCA[/TD]
[/TR]
[TR]
[TD]2009[/TD]
[TD]
Eli Lilly[SUP]
[8][/SUP][/TD]
[TD]$1.4 billion[/TD]
[TD]Off-label promotion[/TD]
[TD]
Zyprexa[/TD]
[TD]False Claims Act/FDCA[/TD]
[/TR]
[TR]
[TD]2001[/TD]
[TD]
TAP Pharmaceutical Products[SUP]
[9][/SUP][/TD]
[TD]$875 million[/TD]
[TD]
Medicare fraud/kickbacks[/TD]
[TD]
Lupron[/TD]
[TD]False Claims Act/
Prescription Drug Marketing Act[/TD]
[/TR]
[TR]
[TD]2012[/TD]
[TD]
Amgen[SUP]
[10][/SUP][/TD]
[TD]$762 million[/TD]
[TD]Off-label promotion/kickbacks[/TD]
[TD]
Aranesp[/TD]
[TD]False Claims Act/FDCA[/TD]
[/TR]
[TR]
[TD]2010[/TD]
[TD]GlaxoSmithKline[SUP]
[11][/SUP][/TD]
[TD]$750 million[/TD]
[TD]Poor manufacturing practices[/TD]
[TD]
Kytril/
Bactroban/
Paxil CR/
Avandamet[/TD]
[TD]False Claims Act/FDCA[/TD]
[/TR]
[TR]
[TD]2005[/TD]
[TD]
Serono[SUP]
[12][/SUP][/TD]
[TD]$704 million[/TD]
[TD]Off-label promotion/
kickbacks/
monopoly practices[/TD]
[TD]
Serostim[/TD]
[TD]False Claims Act[/TD]
[/TR]
[TR]
[TD]2008[/TD]
[TD]
Merck[SUP]
[13][/SUP][/TD]
[TD]$650 million[/TD]
[TD]Medicare fraud/kickbacks[/TD]
[TD]
Zocor/
Vioxx/
Pepsid[/TD]
[TD]False Claims Act/
Medicaid Rebate Statute[/TD]
[/TR]
[TR]
[TD]2007[/TD]
[TD]
Purdue Pharma[SUP]
[14][/SUP][/TD]
[TD]$601 million[/TD]
[TD]Off-label promotion[/TD]
[TD]
Oxycontin[/TD]
[TD]False Claims Act[/TD]
[/TR]
[TR]
[TD]2010[/TD]
[TD]
Allergan[SUP]
[15][/SUP][/TD]
[TD]$600 million[/TD]
[TD]Off-label promotion[/TD]
[TD]
Botox[/TD]
[TD]False Claims Act/FDCA[/TD]
[/TR]
[TR]
[TD]2010[/TD]
[TD]
AstraZeneca[SUP]
[16][/SUP][/TD]
[TD]$520 million[/TD]
[TD]Off-label promotion/kickbacks[/TD]
[TD]
Seroquel[/TD]
[TD]False Claims Act[/TD]
[/TR]
[TR]
[TD]2007[/TD]
[TD]
Bristol-Myers Squibb[SUP]
[17][/SUP][/TD]
[TD]$515 million[/TD]
[TD]Off-label promotion/
kickbacks/Medicare fraud[/TD]
[TD]
Abilify/
Serzone[/TD]
[TD]False Claims Act/FDCA[/TD]
[/TR]
[TR]
[TD]2002[/TD]
[TD]
Schering-Plough[SUP]
[18][/SUP][/TD]
[TD]$500 million[/TD]
[TD]Poor manufacturing practices[/TD]
[TD]
Claritin[/TD]
[TD]
FDA Current
Good Manufacturing Practices[/TD]
[/TR]
[TR]
[TD]2006[/TD]
[TD]Schering-Plough[SUP]
[19][/SUP][/TD]
[TD]$435 million[/TD]
[TD]Off-label promotion/
kickbacks/Medicare fraud[/TD]
[TD]
Temodar/
Intron A/
K-Dur/
Claritin RediTabs[/TD]
[TD]False Claims Act/FDCA[/TD]
[/TR]
[TR]
[TD]2004[/TD]
[TD]Pfizer[SUP]
[20][/SUP][/TD]
[TD]$430 million[/TD]
[TD]Off-label promotion[/TD]
[TD]
Neurontin[/TD]
[TD]False Claims Act/FDCA[/TD]
[/TR]
[TR]
[TD]2008[/TD]
[TD]
Cephalon[SUP]
[21][/SUP][/TD]
[TD]$425 million[/TD]
[TD]Off-label promotion[SUP]
[22][/SUP][/TD]
[TD]
Actiq/
Gabitril/
Provigil[/TD]
[TD]False Claims Act/FDCA[/TD]
[/TR]
[TR]
[TD]2010[/TD]
[TD]
Novartis[SUP]
[23][/SUP][/TD]
[TD]$423 million[/TD]
[TD]Off-label promotion/kickbacks[/TD]
[TD]
Trileptal[/TD]
[TD]False Claims Act/FDCA[/TD]
[/TR]
[TR]
[TD]2003[/TD]
[TD]AstraZeneca[SUP]
[24][/SUP][/TD]
[TD]$355 million[/TD]
[TD]Medicare fraud[/TD]
[TD]
Zoladex[/TD]
[TD]Prescription Drug Marketing Act[/TD]
[/TR]
[TR]
[TD]2004[/TD]
[TD]Schering-Plough[SUP]
[25][/SUP][/TD]
[TD]$345 million[/TD]
[TD]Medicare fraud/kickbacks[/TD]
[TD]
Claritin[/TD]
[TD]False Claims Act/
Anti-Kickback Statute[/TD]
[/TR]
[/TABLE]